Irish Medicines Board safety warnings: do they affect prescribing rates in primary care?
- 19 July 2011
- journal article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 20 (9), 979-986
- https://doi.org/10.1002/pds.2199
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Triple antiplatelet therapy for preventing vascular events: a systematic review and meta-analysisBMC Medicine, 2010
- Optimization of antiplatelet/antithrombotic therapy for secondary stroke preventionAnnals of Indian Academy of Neurology, 2010
- An Appraisal of Dual Antiplatelet Therapy with Clopidogrel and Aspirin for Prevention of Cardiovascular EventsThe Journal of the American Board of Family Medicine, 2009
- Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time seriesJournal of Antimicrobial Chemotherapy, 2007
- Antibiotic use in ambulatory care in Europe (ESAC data 1997–2002): trends, regional differences and seasonal fluctuationsPharmacoepidemiology and Drug Safety, 2006
- General practitioners' perceptions of antimicrobial resistance: a qualitative studyJournal of Antimicrobial Chemotherapy, 2006
- Over and under-utilization of cyclooxygenase-2 selective inhibitors by primary care physicians and specialistsJournal of General Internal Medicine, 2006
- Segmented regression analysis of interrupted time series studies in medication use researchJournal of Clinical Pharmacy & Therapeutics, 2002
- Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases.Gut, 1992
- Physician attitudes toward the use of type IC antiarrhythmics after the cardiac arrhythmia suppression trial (CAST)The American Journal of Cardiology, 1990